- Report
- January 2026
- 180 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- January 2026
- 180 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- January 2026
- 185 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- November 2025
- 182 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- January 2026
- 185 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- January 2026
- 185 Pages
Global
From €4029EUR$4,500USD£3,459GBP
- Report
- February 2026
- 250 Pages
Global
From €4020EUR$4,490USD£3,451GBP
- Drug Pipelines
- May 2026
- 80 Pages
Global
From €1790EUR$2,000USD£1,537GBP
- Report
- December 2025
- 200 Pages
Global
From €7117EUR$7,950USD£6,110GBP
- Report
- May 2026
- 100 Pages
Global
From €2416EUR$2,699USD£2,074GBP
- Report
- May 2026
- 100 Pages
Global
From €2416EUR$2,699USD£2,074GBP
- Report
- May 2026
- 100 Pages
Global
From €2416EUR$2,699USD£2,074GBP
- Report
- May 2026
- 150 Pages
Global
From €2416EUR$2,699USD£2,074GBP
- Report
- May 2026
- 200 Pages
Global
From €2497EUR$2,789USD£2,144GBP
- Report
- August 2026
- 399 Pages
Global
From €5237EUR$5,850USD£4,496GBP
- Report
- November 2025
- 200 Pages
Global
From €7117EUR$7,950USD£6,110GBP
- Report
- May 2026
- 150 Pages
Global
From €2497EUR$2,789USD£2,144GBP
- Report
- May 2026
- 400 Pages
Global
From €4430EUR$4,949USD£3,804GBP
- Report
- May 2026
- 400 Pages
Global
From €4430EUR$4,949USD£3,804GBP
- Report
- May 2026
- 150 Pages
Global
From €2416EUR$2,699USD£2,074GBP

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more